Limited immunity is a state where your immune system recognizes a pathogen but can’t fully prevent infection. Instead of blocking a virus or bacterium at the door, your body mounts a partial defense that reduces how sick you get without stopping the pathogen from taking hold. This is the most common type of immunity people carry around, and it explains why you can catch the same illness more than once, often with milder symptoms each time.
Limited vs. Sterilizing Immunity
The easiest way to understand limited immunity is to compare it with its opposite: sterilizing immunity. Sterilizing immunity means your body eliminates a pathogen before it can replicate even once, ideally right at the point of entry. High levels of neutralizing antibodies, the kind that physically block a virus from entering your cells, are the main drivers of this response. When sterilizing immunity is working, you never become infectious and never develop symptoms. Measles vaccination in most people is a classic example.
Limited immunity sits below that threshold. Your immune system still remembers the pathogen and responds faster than it would during a first encounter, but not fast enough to prevent the pathogen from replicating. The virus or bacterium gains a foothold, and you may develop mild symptoms, shed the pathogen to others, or both. What limited immunity reliably does is keep the infection from escalating into severe disease. Your body’s memory cells kick in early enough to control the situation before it spirals, even if they can’t prevent it entirely.
Why Immunity Weakens Over Time
One of the main reasons people end up with limited rather than sterilizing immunity is that antibody levels naturally decline after vaccination or infection. Neutralizing antibodies against SARS-CoV-2, for instance, have a half-life of roughly 29 to 60 days after peaking. That means your antibody levels drop by half every one to two months. This waning pattern repeats even after multiple exposures: each booster or breakthrough infection triggers a fresh spike in antibodies followed by another steady decline.
The antibody-producing cells responsible for that initial surge are short-lived. They do their job during the acute immune response and then die off quickly, leaving behind a smaller, stable pool of long-lived memory cells. Those memory cells maintain a low baseline of antibodies and stand ready to ramp up production again if you’re re-exposed, but the ramp-up takes time. During that lag, the pathogen can slip in and start replicating. This is why someone vaccinated six months ago may catch a mild infection that they would have avoided entirely at two weeks post-vaccination.
The Role of T Cells
Antibodies get most of the attention, but T cells are a critical reason limited immunity still protects you from serious illness. While antibodies work outside your cells to intercept pathogens, T cells target cells that are already infected. They recognize viral proteins being displayed on a cell’s surface and either kill that cell directly or release signals that recruit a broader immune response.
T cells have a major advantage over antibodies when it comes to durability. Studies on SARS-CoV-2 show that T-cell responses remain detectable for well over 12 months, even as antibody levels fall. T cells also recognize a wider range of viral proteins than antibodies do. Antibodies typically target the surface proteins a virus uses to enter cells, while T cells can respond to internal proteins that tend to change less as the virus mutates. This broader recognition means T-cell protection is harder for a virus to evade, and it’s a big part of why vaccinated or previously infected people rarely end up hospitalized even when antibodies alone aren’t enough to prevent infection.
How Viruses Outpace Your Defenses
Your immune system isn’t the only thing that changes over time. The pathogen itself evolves, and this is the second major driver of limited immunity. Influenza viruses are the textbook example. Through a process called antigenic drift, small random mutations accumulate in the surface proteins that your antibodies were trained to recognize. Eventually those proteins look different enough that your existing antibodies bind poorly or not at all.
This is a gradual process, and it doesn’t erase your protection overnight. Cross-reactive antibodies, ones that target conserved regions of the virus that haven’t mutated, can still reduce viral load and limit disease severity even if they can’t neutralize the new variant outright. But they aren’t precise enough to stop infection from occurring. The result is limited immunity: you’re partially protected, not fully protected. A more dramatic version of this, called antigenic shift, happens when a virus acquires entirely new surface proteins, often by jumping from an animal host. In that scenario, most people have little to no pre-existing immunity at all.
How Long Protection Lasts
The durability of immunity varies significantly by pathogen. Natural immunity to influenza can extend beyond 15 months, with some studies tracking meaningful protection for as long as seven years, though antibody levels drop by about 50% within 3.5 to 7 years. SARS-CoV-2 immunity from a natural infection generally lasts 6 to 12 months before reinfection becomes common. RSV is at the shorter end of the spectrum, with memory T-cell responses declining noticeably within 3 to 4 months.
Vaccine-induced immunity follows a similar pattern of gradual decline. For COVID-19 vaccines, protection against hospitalization among adults 65 and older remained around 78 to 82% at five months or more after vaccination, a meaningful drop from peak effectiveness but still substantial protection against severe outcomes. This is limited immunity in action: the vaccines no longer block infection reliably at that point, but they continue to prevent the worst outcomes.
No Sharp Cutoff Exists
One important nuance is that there’s no clean dividing line between “protected” and “not protected.” Research into antibody thresholds has consistently found that protection changes gradually as antibody levels rise or fall. There is no specific titer below which you’re suddenly vulnerable or above which you’re safe. Scientists often reference a “50% protective threshold,” the antibody level at which a population has a 50-50 chance of avoiding infection, but this is a statistical benchmark, not a biological switch. Your actual risk at any given moment depends on your antibody levels, T-cell memory, the specific variant circulating, and the size of your exposure.
This gradient nature is also why the term “limited immunity” isn’t a formal diagnosis. It describes a spectrum. Someone three months after a booster with moderate antibody levels has more limited immunity than someone three weeks out, but far more protection than someone who has never been exposed at all.
Boosters and Maintaining Protection
Because immunity wanes predictably, booster doses are timed to refresh your antibody levels before they drop too low. Current U.S. guidelines recommend that adults 65 and older and people with moderate or severe immune compromise receive a second seasonal COVID-19 vaccine dose six months after their previous one, with a minimum interval of two months when circumstances warrant earlier protection. People with significant immune compromise may receive three or more doses in a single season based on their individual risk.
The goal of boosters isn’t necessarily to restore sterilizing immunity, though that can happen briefly after each dose. The primary aim is to keep your immune memory sharp enough to prevent severe disease. Each re-exposure to the antigen, whether through vaccination or natural infection, also pushes your B cells through additional rounds of refinement, producing antibodies that bind more tightly and broadly. Over time, this process can improve the quality of your limited immunity even as the quantity of antibodies continues to cycle up and down.